InsideTrading SEC Form 4 insider trades
← All clusters
SPRO

Spero Therapeutics, Inc.

Healthcare Pharmaceutical Preparations Market cap: $58.2M Ticker page → Watch SPRO (just your e-mail) Price alert (just your e-mail)

Limited buying: $21.1M bought (counted up to $5.0M); 6 distinct insiders. Holding it back: largest buyer: Sendek Joel (CFO), 28% of the dollars.

More than 30% below the insider price

50
Insider ScoreThe number from 0 to 100 shown on each cluster and used to rank the lists. By default it is the match score, plus the points of the AI review when there is one. It describes the buying; it is not a forecast or a recommendation. <60 · limited buying
-202.0%
Since the cluster formed, vs benchmark (-92.1% raw)

Score, not a recommendation.

Total bought$21.1M6 Form 4 purchases
Distinct insiders6open-market buyers
Insiders' average price$14.00-92.9% to the latest close
Cluster window2017-11-06single day · closed

partial dataAn input is missing, usually the market cap or the price history. A missing input counts as neutral in the score and is never estimated. Price history is incomplete; missing inputs count as neutral in the score.

check The $21.1M bought is a large share of the $58.2M market cap. That can come from a data error or an entity subscription. Check the filings below.

same price, one day All 6 purchases were at $14.00 on 2017-11-06. That pattern also occurs in IPO or conversion subscriptions, which are not open-market conviction buying.

Price and insider purchases

Live chart from Yahoo Finance, loaded through this server; our daily closes when it is unavailable.

Loading price history…

How the score adds up

How each input is counted →
Points each input adds to the score, and how much of the points it could give it has
Input Strength Points
$21.1M bought (counted up to $5.0M)The dollars the insiders bought, a purchase reported jointly counted once, counted from $131. Each tenfold adds 12.4 points, up to $5.0M; more adds nothing. The bar is empty at $10.0K and full at $5.0M. 100% +57
6 distinct insidersHow many different insiders bought. Each extra insider adds less than the one before (the points follow the log of the count: 4.3 per doubling). The bar is full at 10 insiders. 78% +11
No CEO among the buyersWhether the chief executive is among the buyers: 10.6 points when yes. 0% +0
Stock 0% below its 1-year highHow far the stock had fallen from its highest close of the past year, at the close before the buying. Every 10% of fall adds 1.9 points. A fall beyond 30% adds nothing more. The bar is full at a 30% fall. 0% +0
0 days from first to last purchaseDays between the first and the last purchase. Each day takes off 0.11 points: buying close together keeps more. The bar is empty at 60 days. 100% +0
Routine or plan purchases: 0% of the dollarsThe share of the dollars in routine or plan purchases (a Rule 10b5-1 plan, dividend reinvestment, a regular cadence). All of it routine would take off 5.6 points. 100% +0
Largest buyer: Sendek Joel (CFO), 28% of the dollarsThe share of the dollars bought by the largest buyer. Buying spread evenly keeps the points; one buyer paying for everything takes off 12.7. 86% -4
Match scoreA score from 0 to 100 worked out from the dollars bought, the number of insiders, whether a CEO bought, how far the stock had fallen, how spread out the purchases were and how much came from one buyer. Its weights were calibrated on past clusters. It is the default ranking of the lists and it decides which clusters get the AI review. It describes the buying; it is not a forecast.64
Pipeline flagsPoints taken off because the filings themselves show this buying was an offering, a plan or a 10b5-1 programme. Used only when there is no AI review; from Form 4 footnotes, 8-K filings and prices. (IPO or offering)-14
Insider ScoreThe number from 0 to 100 shown on each cluster and used to rank the lists. By default it is the match score, plus the points of the AI review when there is one. It describes the buying; it is not a forecast or a recommendation.50

Why are they buying?

No explanation has been generated for this cluster. The filings in the table below are the primary evidence.

Transactions

6 Form 4 trades · 6 insiders Download CSV Up to 5,000 rows
Purchases in this cluster, grouped by insider, largest first
Date InsiderAn officer or director of a company, or an owner of more than 10% of its shares. The law requires them to report their trades in the company's stock to the SEC. Role Shares Price Value Flags Filing
2017-11-06 Goyal Vikas history of Goyal Vikas's purchases Director 428,571 $14.00 $6.0M
offering
SEC filing for Goyal Vikas (opens in a new tab)
2017-11-06 FORMELA JEAN FRANCOIS history of FORMELA JEAN FRANCOIS's purchases Director 428,571 $14.00 $6.0M
offering
SEC filing for FORMELA JEAN FRANCOIS (opens in a new tab)
2017-11-06 GLAXOSMITHKLINE PLC history of GLAXOSMITHKLINE PLC's purchases 10% owner 428,571 $14.00 $6.0M
offering
SEC filing for GLAXOSMITHKLINE PLC (opens in a new tab)
2017-11-06 Breum Casper history of Breum Casper's purchases Director 214,285 $14.00 $3.0M
offering
SEC filing for Breum Casper (opens in a new tab)
2017-11-06 Sendek Joel history of Sendek Joel's purchases CFO 5,000 $14.00 $70.0K
offering
SEC filing for Sendek Joel (opens in a new tab)
2017-11-06 Larkin Cristina history of Larkin Cristina's purchases COO 1,500 $14.00 $21.0K
offering
SEC filing for Larkin Cristina (opens in a new tab)
Total $21.1M

What happened next

A buying runPurchases at one company with no pause longer than the cluster rule allows. A long pause ends the run, so one company can have several. ends after a pause in the buying, so one company can have several. Returns are the stock's return minus its benchmarkThe index a stock's return is compared with: a small-cap index for small companies, a large-cap index otherwise. (IWM for small companies, SPY otherwise), from the first open after the buying run became a cluster. Past results, not a forecast.

After this buying run became a cluster, vs benchmark: 21 days -18.9% (-16.1% raw)63 days -6.3% (-5.1% raw)126 days -9.8% (-3.8% raw)